Evidence map›Paper›PMID 32974172›Full record

ArticleFrontiers in oncology2020

Elisa Gelli, Chiara Fallerini, Floriana Valentino, Annarita Giliberti, Francesca Castiglione, Lucrezia Laschi, Maria Palmieri, Alessandra Fabbiani, Rossella Tita, Maria Antonietta Mencarelli and 2 more

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Elisa GelliMedical Genetics, University of Siena, Siena, Italy.
Chiara FalleriniMedical Genetics, University of Siena, Siena, Italy.
Floriana ValentinoMedical Genetics, University of Siena, Siena, Italy.
Annarita GilibertiMedical Genetics, University of Siena, Siena, Italy.
Francesca CastiglioneHistopathogy and Molecular Diagnostics, Careggi University Hospital Florence, Florence, Italy.
Lucrezia LaschiDepartment of Health Sciences, University of Florence, Florence, Italy.
Maria PalmieriMedical Genetics, University of Siena, Siena, Italy.
Alessandra FabbianiMedical Genetics, University of Siena, Siena, Italy.
Rossella TitaGenetica Medica, Azienda Ospedaliera Universitaria Senese, Siena, Italy.
Maria Antonietta MencarelliGenetica Medica, Azienda Ospedaliera Universitaria Senese, Siena, Italy.
Alessandra RenieriMedical Genetics, University of Siena, Siena, Italy.
Francesca ArianiMedical Genetics, University of Siena, Siena, Italy.
Azienda Ospedaliera Universitaria Senese · ITUniversity of Siena · ITAzienda Ospedaliero-Universitaria Careggi · ITUniversity of Florence · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malignant ovarian germ cell tumors (MOGCTs) are neoplasms of the ovary, of which, due to their rarity and heterogeneity, few is reported about genetic background and development. Here, we report a 18-years old patient diagnosed with an ovarian mixed germ cell tumor, without any previous history of malignancies, who has been treated with surgery and chemotherapy and died 4 years later due to peritoneal metastasis complications. Patient's blood DNA was screened for a panel of 52 cancer-related genes in order to identify predisposing aberrations to this rare cancer. The analysis discovered the uncharacterized c.2393G>A variant in

Indexed as

hypomorphic variantovarian cancerRB1tumor predispositionyolk sac tumor

Identifiers

PMID32974172
PMCPMC7471930
OpenAlexW3066509370

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.